Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations

Introduction: Unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients. Materials and Methods: We performed survival analyses of lung squamous cell carcinoma patients harboring therapeutically relevant alterations identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Asim, Mishra, Rohit, Desai, Sanket, Chandrani, Pratik, Kore, Hitesh, Sunder, Roma, Hait, Supriya, Iyer, Prajish, Trivedi, Vaishakhi, Choughule, Anuradha, Noronha, Vanita, Joshi, Amit, Patil, Vijay, Menon, Nandini, Kumar, Rajiv, Prabhash, Kumar, Dutt, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984830/
https://www.ncbi.nlm.nih.gov/pubmed/33796225
http://dx.doi.org/10.18632/oncotarget.27905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984830/
https://www.ncbi.nlm.nih.gov/pubmed/33796225
http://dx.doi.org/10.18632/oncotarget.27905

Ejemplares similares